FdaApplication
BLA 761169
Identifiers
- fda_app_no: BLA761169
Properties
| Property | Value |
|---|---|
| applicant_name | Regeneron Pharmaceuticals, Inc. |
| application_type | BLA |
| approval_date | 2020-10-14 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| INMAZEB | ATOLTIVIMAB; ODESIVIMAB; MAFTIVIMAB | 241.7MG, 241.7MG, 241.7MG/14.5ML (16.67MG, 16.67MG, 16.67MG/ML) | SOLUTION;INJECTION |
| INMAZEB | — | 483.3MG, 483.3MG, 483.3MG/14.5ML (33.33MG, 33.33MG, 33.33MG/ML) | Injection |
2 products